Survival Benefits of Metformin for Colorectal Cancer Patients with Diabetes: A Systematic Review and Meta-Analysis

BACKGROUND: Several studies suggest that metformin has the potential effect of reducing cancer risk. However, its survival benefit in patients with colorectal cancer (CRC) and diabetes is unknown. The aim of our study is to address the effect of metformin on outcomes for CRC based on a systematic re...

Descripción completa

Detalles Bibliográficos
Autores principales: Mei, Zu-Bing, Zhang, Zhi-Jiang, Liu, Chen-Ying, Liu, Yun, Cui, Ang, Liang, Zhong-Lin, Wang, Guang-Hui, Cui, Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960145/
https://www.ncbi.nlm.nih.gov/pubmed/24647047
http://dx.doi.org/10.1371/journal.pone.0091818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960145/
https://www.ncbi.nlm.nih.gov/pubmed/24647047
http://dx.doi.org/10.1371/journal.pone.0091818

Ejemplares similares